Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
Category:
12 June 2020
AGREEMENT RELATED TO THE PATENT BOX REGIME SIGNED WITH THE REVENUE OFFICE
25 May 2020
PHARMANUTRA S.P.A. TAKES PART IN THE AIM ITALIA CONFERENCE 2020
07 May 2020
CETILARĀ® OBTAINS PLAY SURE DOPING FREE CERTIFICATION
29 April 2020
PHARMANUTRA S.P.A.:NEW DISTRIBUTION AGREEMENTS IN EUROPE, ASIA AND LATIN AMERICA.
27 April 2020
PHARMANUTRA S.P.A.: ORDINARY SHAREHOLDERSā MEETING OF 27th APRIL 2020
16 April 2020
PRESENTATION OF PROPOSALS FOR APPOINTMENTS TO THE BOARD OF DIRECTORS OF PHARMANUTRA S.P.A.
15 April 2020
PHARMANUTRA S.P.A.: PFIZER INVESTS IN SUCROSOMIALĀ® TECHNOLOGY
09 April 2020
PHARMANUTRA S.P.A.: NOTICE OF CALL FOR ORDINARY SHAREHOLDERSā MEETING
06 April 2020
PHARMANUTRA S.P.A.: PROPOSAL TO AUTHORISE THE PURCHASE AND DISPOSAL OF TREASURY STOCK
03 April 2020
PHARMANUTRA S.P.A.: FIGURES FOR THE FIRST QUARTER 2020 GROWING
25 March 2020
PHARMANUTRA S.P.A. OBTAINS APPROVAL FOR TWO NEW PATENTS IN INDIA AND UNITED STATES
23 March 2020
PHARMANUTRA S.P.A.: DOUBLE FIGURE GROWTH CONTINUES
23 March 2020
PHARMANUTRA S.P.A.: COMUNICAZIONE AI SOCI IN MERITO AL DECRETO LEGGE āCURA ITALIAā EMANATO DAL GOVERNO
10 March 2020
PHARMANUTRA S.P.A SUPPORTING THE NATIONAL HEALTH SERVICE IN THIS EMERGENCY
05 March 2020
PHARMANUTRA S.P.A. LANCIA LA NUOVA CAMPAGNA MULTICANALE āFATTI TROVARE PRONTOā DEDICATA AD APPORTALĀ®.
07 February 2020
NEW AGREEMENTS FOR THE DISTRIBUTION OF SIDERALĀ® IN MEXICO, THE CZECH REPUBLIC AND SLOVAKIA
03 February 2020
PHARMANUTRA S.P.A.: CORPORATE EVENTS CALENDAR 2020
16 January 2020
PHARMANUTRA S.P.A. PRESENTE ALLA SECONDA EDIZIONE DELLāāITALIAN MID CAP CONFERENCEā DI MEDIOBANCA.
08 January 2020
PharmaNutra S.p.A. engages Mediobanca S.p.A. as Specialist
08 January 2020
Food supplement market is growing in Italy and SiderALĀ® Forte 20 capsules is the most sold nutritional supplement in the country.
19 December 2019
MEDIOBANCA ā BANCA DI CREDITO FINANZIARIO S.P.A. STARTS SHARE COVERAGE
<
1
…
7
8
9
…
12
>
